Omeros Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6821431029
USD
10.28
0.64 (6.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rigel Pharmaceuticals, Inc.
Omeros Corp.
Scilex Holding Co.
Astria Therapeutics, Inc.
Merrimack Pharmaceuticals, Inc.
PolyPid Ltd.
Acrivon Therapeutics, Inc.
Allakos, Inc.
Eagle Pharmaceuticals, Inc.
Lyra Therapeutics, Inc.
Regencell Bioscience Holdings Ltd.

Why is Omeros Corp. ?

1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at -6.55% over the last 5 years
  • The company has a negative book value of Rs 220.48 crore
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 219.25%, its profits have risen by 37.9%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Omeros Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Omeros Corp.
219.25%
0.88
189.33%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-6.55%
EBIT to Interest (avg)
-6.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.64
Sales to Capital Employed (avg)
0.10
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
56.29%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.18
EV to EBIT
-7.88
EV to EBITDA
-7.94
EV to Capital Employed
10.39
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-131.97%
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -101.14 MM

NET PROFIT(HY)

Higher at USD 174.15 MM

RAW MATERIAL COST(Y)

Fallen by -9,165% (YoY

NET SALES(9M)

Higher at USD 9.89 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 16.4 times

DEBTORS TURNOVER RATIO(HY)

Highest at 0.27 times

OPERATING PROFIT(Q)

Highest at USD -17.18 MM

-10What is not working for the Company
INTEREST(HY)

At USD 14.62 MM has Grown at 114.02%

PRE-TAX PROFIT(Q)

At USD -21.84 MM has Fallen at -172.93%

NET PROFIT(Q)

At USD -21.82 MM has Fallen at -175.98%

Here's what is working for Omeros Corp.

Net Sales
At USD 9.89 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -101.14 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD -17.18 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Inventory Turnover Ratio
Highest at 16.4 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 0.27 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Higher at USD 9.89 MM
than preceding 12 month period ended Mar 2026
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost
Fallen by -9,165% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Omeros Corp.

Interest
At USD 14.62 MM has Grown at 114.02%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit
At USD -21.84 MM has Fallen at -172.93%
over average net sales of the previous four periods of USD 29.95 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -21.82 MM has Fallen at -175.98%
over average net sales of the previous four periods of USD 28.71 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)